These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 14648658)

  • 41. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
    J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma.
    Davis LM; Harris C; Tang L; Doherty P; Hraber P; Sakai Y; Bocklage T; Doeden K; Hall B; Alsobrook J; Rabinowitz I; Williams TM; Hozier J
    J Mol Diagn; 2007 Jul; 9(3):327-36. PubMed ID: 17591932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer.
    Jonsdottir K; Zhang H; Jhagroe D; Skaland I; Slewa A; Björkblom B; Coffey ET; Gudlaugsson E; Smaaland R; Janssen EA; Baak JP
    Breast Cancer Res Treat; 2012 Sep; 135(2):381-90. PubMed ID: 22772381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
    Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.
    Rakha EA; El-Rehim DA; Paish C; Green AR; Lee AH; Robertson JF; Blamey RW; Macmillan D; Ellis IO
    Eur J Cancer; 2006 Dec; 42(18):3149-56. PubMed ID: 17055256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer.
    Climent J; Martinez-Climent JA; Blesa D; Garcia-Barchino MJ; Saez R; Sánchez-Izquierdo D; Azagra P; Lluch A; Garcia-Conde J
    Clin Cancer Res; 2002 Dec; 8(12):3863-9. PubMed ID: 12473601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microsatellite analysis of breast carcinoma and corresponding local recurrences.
    Regitnig P; Moser R; Thalhammer M; Luschin-Ebengreuth G; Ploner F; Papadi H; Tsybrovskyy O; Lax SF
    J Pathol; 2002 Oct; 198(2):190-7. PubMed ID: 12237878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
    J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a,bNOMO): clinicopathologic features and outcome.
    Lee AK; Loda M; Mackarem G; Bosari S; DeLellis RA; Heatley GJ; Hughes K
    Cancer; 1997 Feb; 79(4):761-71. PubMed ID: 9024714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early distant relapse in "node-negative" breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumour.
    Colpaert C; Vermeulen P; Jeuris W; van Beest P; Goovaerts G; Weyler J; Van Dam P; Dirix L; Van Marck E
    J Pathol; 2001 Apr; 193(4):442-9. PubMed ID: 11276002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Special clinical and follow-up aspects of invasive lobular breast cancer].
    Mitze M; Meyer F; Goepel E; Kleinkauf-Houcken A; Jonat W
    Geburtshilfe Frauenheilkd; 1991 Dec; 51(12):973-9. PubMed ID: 1794684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up.
    Bult P; Manders P; Straatman HM; Tjan-Heijnen VC; Beex LV; Hendriks J; Leer JW; Verbeek AL; Holland R
    Breast Cancer Res Treat; 2010 Jul; 122(1):77-86. PubMed ID: 19760038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer.
    Gudlaugsson E; Skaland I; Janssen EA; van Diest PJ; Voorhorst FJ; Kjellevold K; zur Hausen A; Baak JP
    Breast Cancer Res Treat; 2010 May; 121(1):35-40. PubMed ID: 19568929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Follow-up of 551 patients with node-negative breast cancer].
    Eidtmann H; Jonat W; Lange C; Friedrichs K; Maass H
    Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):454-61. PubMed ID: 1397940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
    Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.
    Shen J; Hunt KK; Mirza NQ; Krishnamurthy S; Singletary SE; Kuerer HM; Meric-Bernstam F; Feig B; Ross MI; Ames FC; Babiera GV
    Cancer; 2004 Sep; 101(6):1330-7. PubMed ID: 15316905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.